Results 131 to 140 of about 44,745 (290)
Bioluminescence imaging of TNBC intracranial tumor model.
(A) Dynamic changes in intracranial tumor growth after treatment as measured by bioluminescence imaging in photons/second. Groups are as follows: Control (black), non-liposomal doxorubicin (NonL-doxo, green), PEGylated liposomal doxorubicin [PLD] (blue),
Tal Kafri (220972) +14 more
core +1 more source
An endoplasmic reticulum (ER)‐targeted chemodynamic nanoagent (TCBQ/iLD‐ER NPs) comprising •OH‐generating tetrachloro‐1,4‐benzoquinone (TCBQ) and lipid droplets (LDs) formation inhibitor (iLD) is developed for chemodynamic immunotherapy of tumors. After ingestion by cancer cells, TCBQ/iLD‐ER NPs preferentially accumulate in the ER and react with ER ...
Huilan Cai +12 more
wiley +1 more source
In vivo dual substrate bioluminescent imaging.
Our understanding of how and when breast cancer cells transit from established primary tumors to metastatic sites has increased at an exceptional rate since the advent of in vivo bioluminescent imaging technologies. Indeed, the ability to locate and quantify tumor growth longitudinally in a single cohort of animals to completion of the study as opposed
Wendt, Michael K. +3 more
openaire +2 more sources
Optimizing bioluminescence imaging to study protozoan parasite infections.
Bioluminescence imaging is a non-invasive technique which can be used to monitor infections in real-time. However, its utility is restricted by difficulties in detecting pathogens in deep tissue.
Kelly, John M, Taylor, Martin C
core +1 more source
A novel dual‐atom manganese MRI contrast agent (Mn‐BN) with a unique asymmetric coordination geometry provided a promising platform for sensitive and specific tumor imaging. In mice model, Mn‐BN nanoparticles precisely functioned as both a primary tumor‐specific enhancer in subcutaneous models and a hepatocyte‐specific agent in liver metastases models ...
Ding Yang +13 more
wiley +1 more source
A dual-luciferase bioluminescence system for the assessment of cellular therapies
Bioluminescence imaging is a well-established platform for evaluating engineered cell therapies in preclinical studies. However, despite the discovery of new luciferases and substrates, optimal combinations to simultaneously monitor two cell populations ...
Alejandro G. Torres Chavez +8 more
doaj +1 more source
Stem cell therapy has been studied intensively as a promising therapeutic strategy toward a cure for diabetes. To study the effect of mesenchymal stem cell (MSC) transplantation for pancreatic regeneration, we monitored the localization and distribution ...
Song Lee +7 more
doaj +1 more source
Bioluminescence imaging and hematoxylin and eosin staining of subcutaneous tissue.
A, Time course of graft survival as assessed by bioluminescence imaging. B, Quantification of bioluminescence. C, Hematoxylin and eosin staining of serially sectioned subcutaneous tissues collected at days 1, 7, 10, and 14.
Ai Kawamura (651809) +11 more
core +1 more source
A dual‐function cell‐free therapeutic based on DC2.4 cell‐derived exosomes engineered to display BCMA. (Left) Soluble Ligand Sequestration (Decoy Function): DB Exo act as molecular decoys that predominantly sequester soluble APRIL with partial BAFF attenuation, effectively disrupting the NF‐κB survival signaling axis and suppressing myeloma cell ...
Yuqing Zeng +5 more
wiley +1 more source
Development of Firefly Luciferase Bioluminescence for In vivo Optical Imaging
Firefly luciferase is ubiquitously used as a genetic reporter for the non-invasive bioluminescence imaging of small animal models. This widespread use of Firefly luciferase in vivo has been facilitated by genetic engineering producing mutants which are ...
Stowe, Cassandra
core

